- Pfizer Inc.
- Novartis AG
- GlaxoSmithKline PLC
- Teva Pharmaceutical Industries Ltd.
- Sandoz International GMBH
- Aurobindo Pharma Ltd.
- Bausch & Lomb Inc.
- Ranbaxy Laboratories Ltd.
- Daiichi Sankyo Co. Ltd.
- Wockhardt Ltd.
- Sun Pharmaceutical Industries Ltd.
- Aspen Pharmacare Holdings Ltd.
- Zentiva BV
- ratiopharm Group
- Stada Arzneimittel AG
- Actavis Group
- Teva boosts US/key European generics with $9bn Barr purchase
- Pfizer acquires Wyeth in $67bn deal
- Pfizer licenses generics portfolio from Aurobindo Pharma
- Bausch & Lomb, Pfizer co-promote five eye drugs
- Daiichi to buy majority of Indian generics giant Ranbaxy
- GSK partners with Aspen/Strides JV in emerging markets
- Sanofi bids to take the rest of Zentiva
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.